SITUS JUDI MBL77 SECRETS

Not all individuals with CLL call for therapy. In spite of all current advances, the iwCLL nonetheless suggests watchful observation for clients with asymptomatic disease.86 This suggestion is based on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104